AICS-0109-056
UCSFi001-A-M
General
Cell Line |
|
| hPSCreg name | UCSFi001-A-M |
| Cite as: | UCSFi001-A-M |
| Alternative name(s) |
AICS-0109-056
|
| Cell line type | Human induced pluripotent stem cell (hiPSC) |
| Similar lines |
UCSFi001-A-89 (AICS-0097-102) UCSFi001-A-90 (AICS-0097-141) UCSFi001-A-91 (AICS-0097-157) UCSFi001-A-94 (AICS-0104-003) UCSFi001-A-95 (AICS-0104-085) UCSFi001-A-99 (AICS-0105-030) UCSFi001-A-A (AICS-0105-031) UCSFi001-A-B (AICS-0105-032) UCSFi001-A-C (AICS-0105-057) UCSFi001-A-G (AICS-0106-104) UCSFi001-A-H (AICS-0106-134) UCSFi001-A-I (AICS-0107-009) UCSFi001-A-J (AICS-0107-017) UCSFi001-A-O (AICS-0109-093) UCSFi001-A (wtc11, Wtc11, WTC, WTC11, GM25256) UCSFi001-A-64 (P633L RBM20 iPSCs) UCSFi001-A-1T (PRKD1-G592R-het) UCSFi001-A-1U (PRKD1-G592R-hom) UCSFi001-A-92 (AICS-0097-113) UCSFi001-A-93 (AICS-0097-174) UCSFi001-A-96 (AICS-0104-004) UCSFi001-A-97 (AICS-0104-006) UCSFi001-A-98 (AICS-0105-022) UCSFi001-A-D (AICS-0105-089) UCSFi001-A-E (AICS-0106-040) UCSFi001-A-F (AICS-0106-088) UCSFi001-A-K (AICS-0107-063) UCSFi001-A-L (AICS-0109-055) UCSFi001-A-N (AICS-0109-072) UCSFi001-A-P (AICS-0113-002) UCSFi001-A-Q (AICS-0113-023) UCSFi001-A-R (AICS-0113-030) UCSFi001-A-S (AICS-0113-044) UCSFi001-A-T (AICS-0113-057) UCSFi001-A-U (AICS-0113-082) UCSFi001-A-V (AICS-0119-010) UCSFi001-A-W (AICS-0119-023) UCSFi001-A-X (AICS-0119-039) UCSFi001-A-Y (AICS-0119-045) UCSFi001-A-74 (FUS-P525L HET 2D1) UCSFi001-A-75 (FUS-P525L HOM 2D2) UCSFi001-A-82 (WTC11-SLC12A3) UCSFi001-A-49 (YH653-MUT-1C8-HET, DYT1-HET-1C8) UCSFi001-A-50 (YH653-MUT-H6-HET, DYT1-HET-H6) UCSFi001-A-51 (YH653-MUT-2F2-HOMO, DYT1-HOMO-2F2) |
| Last update | 4th December 2024 |
| Notes | Subclone of UCSFi001-A-4 Part of disease collection Cardiomyopathy AICS-0109 |
| User feedback | |
Provider |
|
| Generator | Allen Institute for Cell Science (AICS) |
| Distributors | |
| Derivation country | United States |
External Databases |
|
| BioSamples | SAMEA116328255 |
General Information |
|
| * Is the cell line readily obtainable for third parties? |
Yes Research use: allowed
Clinical use: not allowed
Commercial use: not allowed
|
| Subclone of | |
Donor Information
General Donor Information |
|
| Sex | male |
| Ethnicity | Asian |
Phenotype and Disease related information (Donor) |
|
| Diseases | No disease was diagnosed.
|
| Family history | N/A |
| Is the medical history available upon request? | No |
| Is clinical information available? | Limited clinical information - EKG |
Other Genotyping (Donor) |
|
| Is there genome-wide genotyping or functional data available? |
No
|
Donor Relations |
|
| Other cell lines of this donor | |
External Databases (Donor) |
|
| BioSamples | SAMEA5843920 |
Ethics
Also have a look at the ethics information for the parental line
UCSFi001-A
.
| For generation of the cell line, who was the supplier of any recombined DNA vectors or commercial kits used? |
hIPSC Derivation
General |
|
|
The source cell information can be found in the parental cell line
UCSFi001-A.
|
|
Reprogramming method |
|
| Vector type | Non-integrating |
| Vector | Episomal |
Vector free reprogramming |
|
Other |
|
| Derived under xeno-free conditions |
Unknown |
| Derived under GMP? |
Unknown |
| Available as clinical grade? |
Unknown |
Culture Conditions
| Medium |
mTeSR™ 1
|
Characterisation
Microbiology / Virus Screening |
|
| Mycoplasma | Negative |
Genotyping
Karyotyping (Cell Line) |
|
| Has the cell line karyotype been analysed? |
Yes
46,XY
|
Other Genotyping (Cell Line) |
|
Genetic Modification
| Disease/phenotype related modifications |
|
Login to share your feedback, experiences or results with the research community.